RCM
SANA icon

RA Capital Management’s Sana Biotechnology SANA Stock Holding History

RA Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.4M Buy
+18,750,000
New +$60.4M 0.57% 35

Other funds holding SANA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

RA Capital Management's SANA Position: Q2 2026 in Review

RA Capital Management opened a new position in Sana Biotechnology (SANA) in Q2 2026: 18,750,000 shares worth $65.4M. The stake represents 0.57% of the portfolio and ranks #35 among its holdings.

197 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • RA Capital Management held 18,750,000 shares of Sana Biotechnology worth $65.4M as of Q2 2026.
  • Sana Biotechnology was a new RA Capital Management position in Q2 2026.
  • Sana Biotechnology made up 0.57% of RA Capital Management's portfolio in Q2 2026, its #35 holding.
  • 197 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on RA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.